Myocarditis associated with immune-checkpoint inhibitors diagnosed by cardiac magnetic resonance imaging.

IF 0.5 Q4 ONCOLOGY International Cancer Conference Journal Pub Date : 2022-12-13 eCollection Date: 2023-04-01 DOI:10.1007/s13691-022-00588-1
Masafumi Fukumitsu, Ryo Ariyasu, Mitsutomi Ishiyama, Toshiaki Mochizuki, Koichi Takeda, Makiko Ono, Takuya Oyakawa, Aya Ebihara, Aya Nishizawa, Junichi Tomomatsu, Takahiro Kogawa, Shigehisa Kitano, Taro Shiga
{"title":"Myocarditis associated with immune-checkpoint inhibitors diagnosed by cardiac magnetic resonance imaging.","authors":"Masafumi Fukumitsu, Ryo Ariyasu, Mitsutomi Ishiyama, Toshiaki Mochizuki, Koichi Takeda, Makiko Ono, Takuya Oyakawa, Aya Ebihara, Aya Nishizawa, Junichi Tomomatsu, Takahiro Kogawa, Shigehisa Kitano, Taro Shiga","doi":"10.1007/s13691-022-00588-1","DOIUrl":null,"url":null,"abstract":"<p><p>Myocarditis associated with immune-checkpoint inhibitors (ICIs) is a rare, but critical adverse event. Although endomyocardial biopsy (EMB) is the standard for diagnosis of myocarditis, there is a possibility of false negatives due to sampling errors and local nonavailability of EMB, which may hamper the appropriate diagnosis of myocarditis. Therefore, an alternative criterion based on cardiac magnetic resonance imaging (CMRI) combined with clinical presentation has been proposed, but not emphasized sufficiently. We report a case of myocarditis after ICIs administration, which was diagnosed using CMRI in a 48-year-old male with lung adenocarcinoma. CMRI provides an opportunity to diagnose myocarditis during cancer treatment.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"12 2","pages":"109-114"},"PeriodicalIF":0.5000,"publicationDate":"2022-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989058/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Cancer Conference Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13691-022-00588-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/4/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Myocarditis associated with immune-checkpoint inhibitors (ICIs) is a rare, but critical adverse event. Although endomyocardial biopsy (EMB) is the standard for diagnosis of myocarditis, there is a possibility of false negatives due to sampling errors and local nonavailability of EMB, which may hamper the appropriate diagnosis of myocarditis. Therefore, an alternative criterion based on cardiac magnetic resonance imaging (CMRI) combined with clinical presentation has been proposed, but not emphasized sufficiently. We report a case of myocarditis after ICIs administration, which was diagnosed using CMRI in a 48-year-old male with lung adenocarcinoma. CMRI provides an opportunity to diagnose myocarditis during cancer treatment.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过心脏磁共振成像诊断与免疫检查点抑制剂相关的心肌炎。
与免疫检查点抑制剂(ICIs)相关的心肌炎是一种罕见但严重的不良反应。虽然心内膜活检(EMB)是诊断心肌炎的标准,但由于取样错误和当地无法提供 EMB,可能会出现假阴性,这可能会妨碍心肌炎的正确诊断。因此,有人提出了基于心脏磁共振成像(CMRI)结合临床表现的替代标准,但未得到足够重视。我们报告了一例使用 ICIs 后的心肌炎病例,该病例为 48 岁男性,患有肺腺癌,通过 CMRI 诊断出心肌炎。CMRI 为诊断癌症治疗期间的心肌炎提供了机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
14.30%
发文量
57
期刊介绍: This online-only journal publishes original case reports on all types of cancer. In particular, we welcome not only case reports of educational value in the diagnosis and treatment of cancers, but also reports on molecularly analyzed cancer cases, including gene mutations, gene fusions, gene expression, and changes in copy number, regardless of their known clinical significance. Assessing the molecular analysis of a tumor usually requires a “cancer conference” in which experts from various fields discuss it. Even if the authors and their respective “cancer conference” were unable to determine the clinical significance of molecular changes at the time of submission and publication, their data may provide evidence that will help the scientific community develop precision medicine solutions in the future. We welcome case reports with reviews of the literature on similar cases, as they are more useful and valuable to readers than are reports of rare cases. International Cancer Conference Journal is the official publication of the Japan Society of Clinical Oncology (JSCO). - Presents an online-only collection of original case reports on all types of cancer - In particular, welcomes molecularly analyzed cancer cases - The Official Publication of the Japan Society of Clinical Oncology (JSCO)
期刊最新文献
HER2-targeted therapy is changing. A case of gastritis caused by immune checkpoint inhibitor treated with infliximab. A case of grade1 follicular lymphoma diagnosed by laparoscopic lymph node resection: differentiating from late lymph node recurrence of endometrial cancer. A case report of mucinous borderline ovarian tumor with recurrence as invasive carcinoma with high copy number alterations. SMARCA4-deficient uterine tumors in young women: response to immune checkpoint inhibitors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1